Abilita Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Abilita Therapeutics General Information
Description
Developer of a membrane protein drug discovery platform designed to enable the development of therapeutics against challenging drug targets. The company's platform offers directed evolution-based stabilization of GPCRs, ion channels, and transporters; control of specific protein conformational states; and artificial intelligence (AI) and machine learning analysis of proprietary datasets, enabling biotechnology and pharmaceutical companies to discover antibody and small-molecule therapeutics against difficult membrane protein targets.
Contact Information
Website
www.abilitatx.comCorporate Office
- 5785 Oberlin Drive
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 5785 Oberlin Drive
- Suite 100
- San Diego, CA 92121
- United States
Abilita Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 5. Early Stage VC (Series 1) | 09-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 15-Sep-2021 | Completed | Product Development | |||
| 3. Grant | 20-Sep-2016 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 01-Jan-2015 | Completed | Product Development | |||
| 1. Angel (individual) | 01-Jan-2015 | Completed | Product Development |
Abilita Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 177,788 | $0.000010 | 8% | $1.49 | $1.49 | 1x | $1.49 | 2.29% |
| Seed | 2,114,462 | $0.000010 | 8% | $3.55 | $3.55 | 1x | $3.55 | 19.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Abilita Therapeutics Patents
Abilita Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024262910-A1 | Anti-ccr8 antibodies, conjugates, and uses thereof | Pending | 28-Apr-2023 | ||
| EP-4705346-A2 | Anti-ccr8 antibodies, conjugates, and uses thereof | Pending | 28-Apr-2023 | ||
| US-20250092146-A1 | Anti-ccr8 antibodies, conjugates, and uses thereof | Pending | 28-Apr-2023 | ||
| WO-2024227083-A2 | Anti-ccr8 antibodies, conjugates, and uses thereof | Inactive | 28-Apr-2023 | ||
| WO-2024227083-A3 | Anti-ccr8 antibodies, conjugates, and uses thereof | Inactive | 28-Apr-2023 | C07K16/2866 |
Abilita Therapeutics Signals
Abilita Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Two Bear Capital | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| CONNECT (San Diego) | Accelerator/Incubator |
Abilita Therapeutics FAQs
-
When was Abilita Therapeutics founded?
Abilita Therapeutics was founded in 2014.
-
Where is Abilita Therapeutics headquartered?
Abilita Therapeutics is headquartered in San Diego, CA.
-
What is the size of Abilita Therapeutics?
Abilita Therapeutics has 20 total employees.
-
What industry is Abilita Therapeutics in?
Abilita Therapeutics’s primary industry is Drug Discovery.
-
Is Abilita Therapeutics a private or public company?
Abilita Therapeutics is a Private company.
-
What is Abilita Therapeutics’s current revenue?
The current revenue for Abilita Therapeutics is .
-
How much funding has Abilita Therapeutics raised over time?
Abilita Therapeutics has raised $7.5M.
-
Who are Abilita Therapeutics’s investors?
Two Bear Capital, U.S. Department of Health and Human Services, Johnson & Johnson Innovation - JLABS, and CONNECT (San Diego) have invested in Abilita Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process